804 results on '"Rudà, Roberta"'
Search Results
2. Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.
3. Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.
4. Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
5. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group
6. Current and Future Drugs for Brain Tumors Treatment
7. Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data
8. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.
9. Patient and carer involvement in the formulation of research questions: findings from the Italian guideline on palliative care in adults with glioma
10. Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
11. Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study
12. Health professional involvement in the formulation of research questions: findings from the Italian guideline on palliative care in adults with glioma
13. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
14. Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review
15. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
16. Epilepsy in gliomas: recent insights into risk factors and molecular pathways
17. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
18. Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
19. Ependymoma: Evaluation and Management Updates
20. Contributors
21. Newly diagnosed glioblastoma: A review on clinical management
22. Prevention of Brain Metastases: A New Frontier
23. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.
24. Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience
25. Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives.
26. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: a RANO review
27. Prognostic Evaluation of Surgical Re-Resection for Recurrent Glioblastoma Using the Novel RANO Classification for Extent of Resection by The RANO Resect Group
28. Prevention Strategies for Brain Metastasis
29. Epilepsy in CNS Metastases
30. Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)
31. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
32. Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
33. A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas
34. Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative
35. Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement ('low grade appearance') - a report of the RANO resect group
36. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
37. Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology)
38. Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group.
39. Medulloblastoma in adults: an analysis of clinico-pathological, molecular and treatment factors.
40. Clinical Concepts of Brain Tumors
41. Managing Challenging Behaviour in Brain Tumour (BT) Patients
42. Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group
43. The early recognition and diagnosis of neoplastic meningitis
44. SURG-21. THE PROGNOSTIC ROLE OF RE-RESECTION FOR RECURRENT GLIOBLASTOMA: A REPORT OF THE RANO RESECT GROUP USING A NOVEL CLASSIFICATION FOR EXTENT OF RESECTION
45. CNSC-16. MOLECULAR PROFILING AND ACTIONABLE MUTATIONS IN ADULT PATIENTS WITH IDH WILD TYPE GLIOMAS AND GLIONEURONAL AND NEURONAL TUMORS
46. RTID-02. SILMET TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE SILIBININ IN PREVENTING INTRACRANIAL RECURRENCE AFTER COMPLETE RESECTION OF A SINGLE BRAIN METASTASIS FROM NSCLC OR BREAST CANCER
47. NCOG-22. SEIZURE OUTCOME ACROSS DISEASE TRAJECTORY IN IDH-MUTANT GRADE 2 GLIOMAS: WHICH IS THE IMPACT OF STANDARD ANTINEOPLASTIC TREATMENTS?
48. Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
49. Systemic Therapy for Lung Cancer Brain Metastases
50. Leptomeningeal dissemination as a first sign of progression in metastatic melanoma: a diagnostic lesson
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.